Pfizer Inc and BioNTech SE announced that the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age. With the high level of respiratory illnesses currently circulating among children under 5 years of age, updated COVID-19 vaccines may help prevent severe illness and hospitalization.

Union Minister of State (Independent Charge) Science & Technology, Dr Jitendra Singh said, India will make significant investment in R&D to develop a roadmap for design and delivery of vaccine development for future pandemic.

Our Educational Organization Maharishi Parshuram College of Pharmacy is a premier College in Fazilka Punjab (Running D-Pharmacy) with academic excellence Maharishi Parshuram College of Pharmacy is approved by AICTE, PCI New Delhi and Govt. of Punjab.

HOD/ Principal of Diploma Pharmacy College
Qualification – M.Pharma with 5 yrs experience 

Jawaharlal Nehru Centre for Advanced Scientific Research is an autonomous institution that was established in 1989 by the Department of Science and Technology, GoI to commemorate the birth centenary year of Pandit Jawaharlal Nehru. Bharat Ratna Prof. C. N. R. Rao, FRS, was the founding President. The Centre was registered as a society with Dr. Raja Ramanna (eminent physicist and Former Chairman, DAE) as its first Chairman.

Post : Research Associate

Advanced Centre for Treatment, Research and Education in Cancer, ACTREC, is a unique Institute under the wing of Tata Memorial Centre and a grant-in-aid Institution of the Department of Atomic Energy. ACTREC conducts a PhD program in Life Sciences that is affiliated with the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt. of India). Fulfilling its ‘bench-to- bedside’ mandate, the Institute provides a highly conducive environment for world-class cancer research.

The National Institute of Biologicals (NIB) had been set up in 1992. NIB is an apex autonomous institute under the administrative control of Ministry of Health & Family Welfare (MoHFW), Government of India. The Institute is performing primary statutory function of Quality Control of Biologicals e.g. Insulin, erythropoietin, blood products, diagnostic kits e.g. HIV, HBV, HCV, therapeutic monoclonal antibodies like Trastuzumab and Rituximab used in cancer treatment etc.

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from eligible Indian Nationals for the following project positions.

Project Title : “Mission Program on Pediatric Rare Genetic Disorders” (Funded by DBT)
Principal Investigator : Dr. P V Ramchander* & Dr. R. Swain**

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field. 

Post : Senior Executive - NCQ

Ind-Swift Limited - Jawaharpur, Derabassi is the Ace unit of Ind-Swift Limited, was created in the year 2005 with an aim to globalize the Ind-Swift brand for finished dosage forms. We are a 100% Export Oriented Unit dealing in regulated markets having approval like MHRA, TGA & GLC etc.

OPEN POSITIONS for Formulation Site

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.

Post :  EXECUTIVE

Medopharm is a leading manufacturer and a star house exporter of over 600 pharmaceutical products to around 70 countries with a direct/indirect presence. The Chordia group, estimated at USDS320 million, is an amalgamation of three companies including Automobile financing, Pharmaceutical manufacturing and distribution, and Real estate.

New modeling shows how synonymous mutations those that change the DNA sequence of a gene but not the sequence of the encoded protein can still impact protein production and function. A team of researchers led by Penn State chemists modeled how genetic changes that alter the speed of protein synthesis, but not the sequence of amino acids that comprise the protein, can lead to misfolding that changes the protein’s activity level, and then corroborated their models experimentally.

Scientists have identified a drug that can be repurposed to prevent COVID-19 in research involving a unique mix of ‘mini-organs’, donor organs, animal studies and patients.

Novartis announced the pivotal Phase III PSMAfore study with PluvictoTM (INN: lutetium (177Lu) vipivotide tetraxetan), a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, met its primary endpoint. Pluvicto demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) in patients with PSMA–positive metastatic castration-resistant prostate cancer (mCRPC) after treatment with androgen-receptor pathway inhibitor (ARPI) therapy, compared to a change in ARPI1.

The Ministry of Health and Family welfare amended the New Drugs and Clinical Trials Rules, 2019 in consultation with the Drugs Technical Advisory Board, DTAB, and specified non-clinical testing methods to assess the safety and efficacy of a new drug or investigational new drug.

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Junior Materiovigilance Associate

Our laboratory at IIT Hyderabad (with collaboration with hospital) leading by highly energetic interdisciplinary peoples, is working at the interface between materials and biology to develop next-generation nanotechnology approaches for health care products, which is unique and effective. We are seeking talented, motivated and passionate individuals (1 no) to join in our efforts for cutting-age research on “Nano-formulation Based Innovative Health Products”. The candidate will get highly interdisciplinary work environment to perform cutting age research.